Xuhui Bao

1.5k total citations · 2 hit papers
32 papers, 1.1k citations indexed

About

Xuhui Bao is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xuhui Bao has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Xuhui Bao's work include Toxin Mechanisms and Immunotoxins (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Neuroblastoma Research and Treatments (5 papers). Xuhui Bao is often cited by papers focused on Toxin Mechanisms and Immunotoxins (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Neuroblastoma Research and Treatments (5 papers). Xuhui Bao collaborates with scholars based in United States, China and Russia. Xuhui Bao's co-authors include Chuan‐Yuan Li, Mengjie Hu, Meng Jiao, Fang Li, Liyi Xie, Dong Pan, Xinjian Liu, Qian Huang, Jin Cheng and Darell D. Bigner and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Xuhui Bao

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

2020 331 citations Xinjian Liu, Xuhui Bao et al. Nature profile →
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

2024 77 citations Xuhui Bao, Tianji Cai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuhui Bao United States	14	475	396	357	240	192	32	1.1k
Véronique Secq France	15	448 0.9×	278 0.7×	431 1.2×	251 1.0×	110 0.6×	41	1.1k
Els Van Nieuwenhuysen Belgium	20	372 0.8×	180 0.5×	559 1.6×	325 1.4×	128 0.7×	99	1.3k
Hamid Masoudi Canada	17	741 1.6×	304 0.8×	663 1.9×	228 0.9×	88 0.5×	28	1.6k
Kyoung Eun Lee United States	15	556 1.2×	553 1.4×	881 2.5×	362 1.5×	209 1.1×	32	1.5k
Ernst J.A. Steller Netherlands	15	717 1.5×	241 0.6×	741 2.1×	424 1.8×	116 0.6×	20	1.5k
Bernhard Reis Switzerland	13	512 1.1×	507 1.3×	511 1.4×	284 1.2×	86 0.4×	25	1.2k
Anupma Nayak United States	20	416 0.9×	147 0.4×	462 1.3×	379 1.6×	137 0.7×	62	1.1k
Roger Mouawad France	21	523 1.1×	208 0.5×	308 0.9×	177 0.7×	121 0.6×	57	968
Alberto Pisacane Italy	21	486 1.0×	192 0.5×	624 1.7×	269 1.1×	245 1.3×	49	1.4k

Countries citing papers authored by Xuhui Bao

Since Specialization

Citations

This map shows the geographic impact of Xuhui Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuhui Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuhui Bao more than expected).

Fields of papers citing papers by Xuhui Bao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuhui Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuhui Bao. The network helps show where Xuhui Bao may publish in the future.

Co-authorship network of co-authors of Xuhui Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Xuhui Bao. A scholar is included among the top collaborators of Xuhui Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuhui Bao. Xuhui Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elchaninov, Andrey, Polina Vishnyakova, M. Antonova, et al.. (2023). Spleen regeneration after subcutaneous heterotopic autotransplantation in a mouse model. Biological Research. 56(1). 15–15. 4 indexed citations

Pan, Dong, Xuhui Bao, Mengjie Hu, et al.. (2022). SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy. Cancer Research. 82(15). 2748–2760. 31 indexed citations

Liu, Xinjian, Xuhui Bao, Mengjie Hu, et al.. (2020). Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature. 588(7839). 693–698. 331 indexed citations breakdown →

Bao, Xuhui, Xinjian Liu, Fang Li, & Chuan‐Yuan Li. (2020). Limited MOMP, ATM, and their roles in carcinogenesis and cancer treatment. Cell & Bioscience. 10(1). 81–81. 8 indexed citations

Hu, Mengjie, Min Zhou, Xuhui Bao, et al.. (2020). ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation. Journal of Clinical Investigation. 131(3). 173 indexed citations

Xie, Liyi, Xuhui Bao, Tianji Cai, et al.. (2019). Elevated Risk of Radiation Therapy–Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 105(2). 275–284. 4 indexed citations

Chandramohan, Vidya, Xuhui Bao, Scott Parker, et al.. (2019). Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations. Journal for ImmunoTherapy of Cancer. 7(1). 142–142. 38 indexed citations

Evans, Myron K., Michael C. Brown, Joseph Geradts, et al.. (2018). XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype. Cancer Research. 78(7). 1726–1738. 44 indexed citations

Xie, Liyi, Lin Chen, Huan Zhang, & Xuhui Bao. (2018). Second malignancy in young early-stage breast cancer patients with modern radiotherapy. Medicine. 97(17). e0593–e0593. 9 indexed citations

10.

Xie, Liyi, Lin Chen, Qingfu Zhang, et al.. (2018). Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer. Cancer Management and Research. Volume 10. 1329–1340. 6 indexed citations

11.

Bao, Xuhui, Vidyalakshmi Chandramohan, Randall Reynolds, et al.. (2016). Preclinical toxicity evaluation of a novel immunotoxin, D2C7-(scdsFv)-PE38KDEL, administered via intracerebral convection-enhanced delivery in rats. Investigational New Drugs. 34(2). 149–158. 10 indexed citations

12.

Xie, Qing, Xuhui Bao, Richard F. Keep, et al.. (2016). Role of Protease-Activated Receptor-1 in Glioma Growth. Acta neurochirurgica. Supplementum. 121. 355–360. 13 indexed citations

13.

Bao, Xuhui, et al.. (2014). Treatment-related secondary cancer in malignant meningiomas: a population-based study. Journal of Cancer Research and Clinical Oncology. 140(4). 583–588. 5 indexed citations

14.

Chandramohan, Vidyalakshmi, Xuhui Bao, Stephen T. Keir, et al.. (2013). Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy. Clinical Cancer Research. 19(17). 4717–4727. 58 indexed citations

15.

Piao, Hailan, Chien‐Tsun Kuan, Vidya Chandramohan, et al.. (2013). Affinity-matured recombinant immunotoxin targeting gangliosides 3′-isoLM1 and 3′,6'-isoLD1 on malignant gliomas. mAbs. 5(5). 748–762. 8 indexed citations

16.

Chandramohan, Vidyalakshmi, Xuhui Bao, Mika K. Kaneko, et al.. (2012). Recombinant anti‐podoplanin (NZ‐1) immunotoxin for the treatment of malignant brain tumors. International Journal of Cancer. 132(10). 2339–2348. 66 indexed citations

17.

Bao, Xuhui, et al.. (2012). Second malignant neoplasms in childhood malignant brain tumour: A long‐term population‐based study. Journal of Paediatrics and Child Health. 48(11). 990–996. 11 indexed citations

18.

Wu, Gang, Xuhui Bao, Guohua Xi, et al.. (2011). Brain injury after intracerebral hemorrhage in spontaneously hypertensive rats. Journal of neurosurgery. 114(6). 1805–1811. 22 indexed citations

19.

Huang, Fengping, et al.. (2010). Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients. Journal of Neuro-Oncology. 100(1). 113–120. 16 indexed citations

20.

Xie, Liyi, et al.. (2009). Leflunomide for the successful management of juvenile Cogan's syndrome. Clinical Rheumatology. 28(12). 1453–1455. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact